Analyst Price Targets — NOVT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 7, 2026 12:44 pm | — | Robert W. Baird | $194.00 | $168.29 | TheFly | Novanta price target raised to $194 from $180 at Baird |
| June 9, 2026 11:17 am | Quinn Fredrickson | Robert W. Baird | $180.00 | $164.34 | TheFly | Novanta price target raised to $180 from $173 at Baird |
| February 25, 2026 2:21 pm | Robert Mason | Robert W. Baird | $150.00 | $134.67 | TheFly | Novanta price target raised to $150 from $138 at Baird |
| March 3, 2025 12:13 pm | — | Robert W. Baird | $160.00 | $143.37 | TheFly | Novanta price target lowered to $160 from $169 at Baird |
| August 7, 2024 8:59 am | Robert Mason | Robert W. Baird | $175.00 | $174.36 | TheFly | Novanta price target raised to $175 from $170 at Baird |
Latest News for NOVT
Connor Clark and Lunn Investment Management Ltd. acquired a new position in Novanta Inc. (NASDAQ: NOVT) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,845 shares of the technology company's stock, valued at approximately $786,000. Several other large investors have
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird Global Healthcare Conference on Tuesday, September 15, 2026, in New York, NY. About Novanta…
If you are looking for stocks that are well positioned to maintain their recent uptrend, Novanta (NOVT) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Does Novanta (NOVT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Bank of America Corp DE increased its stake in Novanta Inc. (NASDAQ: NOVT) by 18.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 456,241 shares of the technology company's stock after acquiring an additional 70,728 shares during the
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NOVT.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.